Abstract:Objective To investigate the clinical efficacy and safety of transoral 980 nm/1 470 nm dual-wavelength fiber laser surgery for the resection of lingual thyroglossal duct cyst (LTGDC).Methods A retrospective analysis was performed on the clinical data of 10 patients with LTGDC who were admitted from March 2017 to February 2023. All patients underwent transoral dual-wavelength fiber laser surgery under suspension laryngoscope. The data recorded included the patients’ gender, age, cyst diameter, operation time, intraoperative blood loss, length of hospital stay, postoperative sore throat score, complications and recurrence. Postoperative follow-up was conducted for (78.5±29.4) months.Results All 10 patients underwent successful surgery, including 8 (80.0%) primary cases and 2 (20.0%) recurrent cases (both with one previous operation). The patient’s age was (53.4±12.9) years old, with 5 males (50.0%) and 5 females (50.0%). The cyst diameter was (20.3±4.8) mm. The operation time was (17.8±4.0) minutes. The median intraoperative blood loss was 3.5 (2.0, 5.0) mL, and the median hospital stay was 2.0 (1.0, 2.3) days. The postoperative sore throat score showed a significant downward trend (F=79.5, P<0.001): median score was 4.0 (3.0, 4.3) at 1 day, 2.0 (1.8, 2.0) at 1 week, 0.5 (0.0, 1.0) at 2 weeks, and 0.0 (0.0, 0.0) at 1 month postoperatively. There were no postoperative complications such as bleeding, recurrence, epiglottic cartilage injury, pharyngeal fistula, neck scar or tracheotomy.Conclusions Transoral 980 nm/1 470 nm dual-wavelength fiber laser surgery for LTGDC has the advantages of short operation time, less bleeding, short hospital stay, mild postoperative pain, rapid recovery, fewer complications and low recurrence rate. It also shows favorable efficacy for recurrent cases and is a safe and efficient minimally invasive procedure.